Copyright
©The Author(s) 2022.
World J Psychiatry. Feb 19, 2022; 12(2): 298-307
Published online Feb 19, 2022. doi: 10.5498/wjp.v12.i2.298
Published online Feb 19, 2022. doi: 10.5498/wjp.v12.i2.298
Demographic | Category | Total | Medication group | Comparison group |
Number of patients | 1480 | 587 | 893 | |
Age (mean ± SD) | 82.6 ± 8.1 | 81.7 ± 8.4 | 83.3 ± 7.9 | |
Gender | Male | 714 (48.2%) | 294 (50.1%) | 420 (47.0%) |
Female | 766 (51.8%) | 293 (49.9%) | 473 (53.0%) | |
Other/NA | 0 | 0 | 0 | |
Ethnicity | White-British | 1033 (69.8%) | 451 (76.8%) | 582 (65.2%) |
White-Irish | 5 (< 1%) | 4 (< 1%) | 1 (< 1%) | |
White-Any other | 17 (1.1%) | 6 (1.0%) | 11 (1.2%) | |
Mixed-White and Asian | 1 (< 1%) | 1 (< 1%) | 0 (< 1%) | |
Asian-Indian | 6 (< 1%) | 2 (< 1%) | 4 (< 1%) | |
Asian-Bangladeshi | 1 (< 1%) | 0 (< 1%) | 1 (< 1%) | |
Asian-Any other | 10 (< 1%) | 5 (< 1%) | 5 (< 1%) | |
Black-Caribbean | 2 (< 1%) | 1 (< 1%) | 1 (< 1%) | |
Black-African | 2 (< 1%) | 1 (< 1%) | 1 (< 1%) | |
Any other ethnic group | 2 (< 1%) | 2 (< 1%) | 0 (< 1%) | |
Not stated/NA | 401 (27.1%) | 114 (19.4%) | 287 (32.1%) | |
MMSE | Number of patients with MMSE | 608 (41.1%) | 226 (38.5%) | 382 (42.8%) |
Number of patients without MMSE | 876 (58.9%) | 361 (61.5%) | 511 (57.2%) | |
MMSE score | 20-30 | 369 (60.7%) | 101 (44.7%) | 268 (70.2%) |
10-19 | 199 (23.7%) | 98 (43.4%) | 101 (26.4%) | |
< 10 | 40 (6.56%) | 27 (11.9%) | 13 (3.4%) |
Covariate | Total | Alive | Dead | Hazard ratio | P value |
Medications | |||||
Olanzapine | 155 | 33 (21.3%) | 122 (78.7%) | 1.32a (1.08-1.60) | < 0.01 |
Quetiapine | 144 | 29 (20.1%) | 115 (79.9%) | 1.09 (0.90-1.34) | 0.38 |
Risperidone | 450 | 82 (18.2%) | 368 (81.8%) | 1.35b (1.18-1.54) | < 0.001 |
Gender | |||||
Male | 714 | 165 (23.1%) | 549 (76.9%) | Baseline | |
Female | 766 | 218 (28.5%) | 548 (71.5%) | 0.73b (0.64-0.82) | < 0.001 |
Ethnicity | |||||
White-British | 1033 | 275 (26.6%) | 758 (73.4%) | 0.82a (0.72-0.94) | < 0.01 |
White-Irish | 5 | 2 (40.0%) | 3 (60.0%) | 0.51 (0.16-1.62) | 0.26 |
White-Any other | 17 | 6 (35.3%) | 11 (64.7%) | 0.62 (0.34-1.13) | 0.12 |
Mixed-White and Asian | - | - | - | - | - |
Asian-Indian | 6 | 1 (16.7%) | 5 (83.3%) | 1.49 (0.61-3.63) | 0.38 |
Asian-Bangladeshi | - | - | - | - | - |
Asian-Any other | 10 | 6 (60.0%) | 4 (40.0%) | 0.17a (0.05-0.53) | < 0.01 |
Black-Caribbean | - | - | - | - | - |
Black-African | - | - | - | - | - |
Any other ethnic group | - | - | - | - | - |
MMSE score | |||||
20-30 | 369 | 123 (33.3%) | 246 (66.7%) | 0.72b (0.62-0.83) | < 0.001 |
10-19 | 199 | 45 (22.6%) | 154 (77.4%) | 0.87 (0.73-1.04) | 0.12 |
< 10 | 40 | 11 (27.5%) | 29 (72.5%) | 0.81 (0.56-1.19) | 0.28 |
- Citation: Phiri P, Engelthaler T, Carr H, Delanerolle G, Holmes C, Rathod S. Associated mortality risk of atypical antipsychotic medication in individuals with dementia. World J Psychiatry 2022; 12(2): 298-307
- URL: https://www.wjgnet.com/2220-3206/full/v12/i2/298.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i2.298